FBInvestor
Stocks / Uniqure NV
Institutional Ownership

Uniqure NV

CUSIP N90064101SHSQ1 2026

13D / 13G Filings
54
Schedule 13D/13G on record
Beneficial Filers
21
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
205
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

54 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Rtw Investments, LP13G/A6.0%3.71MSEC
2Feb 17, 2026Ecor1 Capital, LLC13G/A1.0KSEC
3Feb 17, 2026Avoro Capital Advisors LLC13G/A9.9%6.15MSEC
4Feb 13, 2026G1 Execution Services, LLC13G5.7%3.54MSEC
5Feb 9, 2026State Street Corporation13G5.2%3.23MSEC
6Jan 29, 2026Aberdeen Group PLC13G/A5.9%3.68MSEC
7Nov 14, 2025Rtw Investments, LP13G/A7.2%4.42MSEC
8Nov 14, 2025Vestal Point Capital, LP13G/A0.4%225.0KSEC
9Nov 5, 2025Fmr LLC13G9.8%6.06MSEC
10Oct 14, 2025Aberdeen Group PLC13G/A4.8%2.94MSEC

44 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Uniqure NV.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Avoro Capital Advisors LLC5.96M$97.44M
2Aberdeen Group PLC5.31M$86.76M
3Two Sigma Investments, LP2.68M$43.75M
4Rtw Investments, LP2.59M$42.29M
5Jpmorgan Chase & Co2.84M$41.80M
6State Street Corp2.26M$36.96M
7Orbimed Advisors LLC2.14M$34.93M
8Fmr LLC1.74M$28.51M
9Blackrock, Inc.1.73M$28.34M
10Mpm Bioimpact LLC1.37M$22.39M